Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
Stanford University
University of California, Davis
City of Hope Medical Center
Stanford University
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
Barbara Ann Karmanos Cancer Institute
University of Wisconsin, Madison
Wake Forest University Health Sciences
Massachusetts General Hospital
University of Louisville
Alliance for Clinical Trials in Oncology
Case Comprehensive Cancer Center
Indiana University
Indiana University
Rutgers, The State University of New Jersey
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Northwestern University
Northwestern University
Mayo Clinic
NYU Langone Health
Roswell Park Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Arizona
Virginia Commonwealth University
Rutgers, The State University of New Jersey
Cambridge Antibody Technology